Authors suggest limiting duration of oral corticosteroid treatment to 90 days or less to reduce risk of adverse effects. HealthDay News — Use of oral corticosteroids for greater than 90 days during 1 ... ascopubs.org: The preventive effects of early short-course corticosteroids on immune-related adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors.
The preventive effects of early short-course corticosteroids on immune-related adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors. Monthly Prescribing Reference: Adverse Event Risk Up for Greater Than 90 Days vs 30 Days of Corticosteroids for Eczema Adverse Event Risk Up for Greater Than 90 Days vs 30 Days of Corticosteroids for Eczema News Medical: Study suggests limiting oral corticosteroid use to 90 days reduces adverse effects in atopic dermatitis patients Study suggests limiting oral corticosteroid use to 90 days reduces adverse effects in atopic dermatitis patients ascopubs.org: Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials
